Our Pricing

Understanding Mounjaro Doses: The UK Clinical Dosing Schedule

Understanding mounjaro doses and their escalation schedule is essential for safe, effective weight loss treatment. At Cured Pharmacy, our UK prescribers follow MHRA-approved dosing protocols, starting patients at 2.5mg and carefully titrating upwards every four weeks to minimise side effects whilst maximising clinical outcomes.

The Standard Mounjaro Doses Escalation Schedule

Mounjaro (tirzepatide) follows a structured dose escalation protocol designed to optimise tolerability whilst achieving therapeutic effect. The MHRA-approved schedule begins at 2.5mg once weekly for four weeks, then increases to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg — each dose maintained for at least four weeks before progression [1]. This gradual titration allows your body to adapt to the medication's effects on GIP and GLP-1 receptors, significantly reducing the likelihood of gastrointestinal side effects that can occur with rapid dose changes.

Clinical data from the SURPASS trials demonstrate that this four-week interval between mounjaro doses produces optimal outcomes. Patients who followed the prescribed escalation schedule experienced fewer treatment discontinuations due to side effects compared to those attempting faster titration [1]. Your UK prescriber at Cured Pharmacy will monitor your progress at each dose level, assessing both weight loss response and tolerability before recommending progression to the next strength.

The starting dose of 2.5mg is not intended to produce significant weight loss — it serves as an initiation dose to help your body adjust to tirzepatide's mechanism of action. Meaningful weight reduction typically begins at the 5mg and 7.5mg doses, with maximum efficacy observed at maintenance doses of 10mg, 12.5mg, or 15mg, depending on individual response and tolerability [2].

When Should You Increase Your Mounjaro Dose?

The decision to increase mounjaro doses should always be made in consultation with your UK prescriber, never independently. The standard protocol requires a minimum of four weeks at each dose level before considering escalation [1]. This interval allows sufficient time to assess your body's response, monitor for side effects, and evaluate weight loss progress. Rushing this timeline increases the risk of nausea, vomiting, diarrhoea, and treatment discontinuation.

Your prescriber will consider several clinical factors when determining readiness for dose escalation: tolerance of your current dose (absence of persistent moderate-to-severe gastrointestinal symptoms), adherence to the weekly injection schedule, weight loss trajectory, and any changes in your medical history or concurrent medications. If you're experiencing ongoing nausea or other side effects at your current dose, your prescriber may recommend remaining at that strength for an additional four weeks rather than escalating [3].

Some patients achieve their weight loss goals at lower maintenance doses (10mg or 12.5mg) and may not require escalation to the maximum 15mg dose. Conversely, others may benefit from reaching the highest dose to optimise metabolic outcomes. The SURPASS-3 trial showed that patients on 15mg tirzepatide achieved an average 22.5% body weight reduction over 72 weeks, compared to 21.1% at 10mg — a clinically meaningful difference for some individuals [1].

Signs You May Need to Delay Dose Escalation

Certain symptoms indicate you should remain at your current mounjaro dose for longer than the standard four weeks. Persistent nausea lasting beyond the first week at a new dose, frequent vomiting (more than twice weekly), severe abdominal pain, or signs of dehydration all warrant discussion with your prescriber before any dose increase. Additionally, if you've experienced a dosing interruption of more than two weeks, you may need to restart at a lower dose rather than continuing escalation [3].

Your UK prescriber at Cured Pharmacy will provide individualised guidance based on your clinical presentation. The goal is sustainable, safe weight loss — not racing to the highest dose. Some patients achieve excellent outcomes remaining at 7.5mg or 10mg for extended periods, particularly if they're experiencing consistent weight loss and minimal side effects at those strengths.

How Mounjaro Doses Compare to Other Weight Loss Treatments

Understanding how mounjaro doses compare to alternative treatments helps contextualise the escalation schedule. Wegovy (semaglutide) follows a similar gradual titration protocol, starting at 0.25mg weekly and escalating to a maximum maintenance dose of 2.4mg over 16-20 weeks [2]. Saxenda (liraglutide) requires daily injections with dose escalation from 0.6mg to 3mg over five weeks. The key difference is tirzepatide's dual GIP/GLP-1 receptor mechanism, which produces greater average weight loss at equivalent treatment durations.

In head-to-head comparisons, the highest mounjaro doses (10mg-15mg) demonstrated superior weight reduction compared to semaglutide 1mg in the SURPASS-2 trial, with patients losing an average of 12.4kg on tirzepatide 15mg versus 6.2kg on semaglutide over 40 weeks [1]. This doesn't mean Mounjaro is universally superior — individual response varies, and some patients may achieve better outcomes or tolerability with semaglutide-based treatments. Your UK prescriber will recommend the most appropriate medication based on your medical history, weight loss goals, and previous treatment responses.

Orlistat-based treatments like Xenical and Alli work through an entirely different mechanism (lipase inhibition) and don't require dose escalation, but produce more modest weight loss — typically 5-10% of body weight compared to 15-22% with optimised mounjaro doses [4]. At Cured Pharmacy, we offer the full range of MHRA-licensed weight loss treatments, allowing your prescriber to select the option most suited to your clinical needs.

Managing Side Effects During Mounjaro Dose Escalation

Gastrointestinal side effects are most common during the first few days after increasing mounjaro doses, typically subsiding within one to two weeks as your body adjusts. Nausea affects approximately 20-30% of patients during dose escalation, with lower incidence rates at steady-state dosing [1]. Practical strategies to minimise these effects include eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking your injection on the same day each week to maintain consistent medication levels.

If you experience persistent nausea or vomiting that interferes with daily activities, contact your prescriber before your next scheduled dose increase. Anti-nausea medications such as domperidone or cyclizine may be prescribed short-term to help you tolerate the escalation, though these are typically only necessary for a minority of patients [3]. Never reduce your dose or skip injections without consulting your prescriber, as inconsistent dosing can worsen side effects and reduce treatment efficacy.

Rare but serious side effects require immediate medical attention regardless of your current mounjaro dose. These include severe abdominal pain that doesn't resolve (potential pancreatitis), persistent vomiting leading to dehydration, visual changes, or signs of thyroid nodules. Your prescriber will review these warning signs during your initial consultation and provide clear guidance on when to seek urgent medical care versus routine follow-up.

Optimising Injection Technique Across All Doses

Proper injection technique remains consistent across all mounjaro doses, but bears repeating as you progress through treatment. Inject subcutaneously into your abdomen, thigh, or upper arm, rotating injection sites weekly to prevent lipohypertrophy (fatty lumps under the skin). The KwikPen device delivers a pre-measured dose — you'll hear a click when the injection is complete, and you should hold the pen in place for five seconds before withdrawing to ensure full dose delivery.

Store unused Mounjaro pens in the refrigerator at 2-8°C, but allow the pen to reach room temperature for 30 minutes before injecting to reduce injection site discomfort. Never freeze Mounjaro, and discard any pens that have been frozen. Once in use, a pen can be stored at room temperature (up to 30°C) for up to 21 days, making it convenient for travel or if refrigeration is temporarily unavailable.

Mounjaro Maintenance Doses: Finding Your Optimal Strength

Once you've completed the escalation schedule, you'll establish a maintenance mounjaro dose — the strength you'll continue long-term to sustain weight loss. For most patients, this is 10mg, 12.5mg, or 15mg weekly, though some achieve their goals at lower doses [1]. The SURPASS trials continued maintenance dosing for up to 72 weeks, demonstrating sustained weight reduction without plateau when patients remained on consistent doses and maintained lifestyle modifications.

Your maintenance dose isn't necessarily the highest dose you can tolerate — it's the strength that balances optimal weight loss with minimal side effects and sustainable long-term use. Some patients find 12.5mg provides excellent results with better tolerability than 15mg, whilst others require the maximum dose to achieve their target weight reduction. Your UK prescriber will schedule regular follow-up consultations (typically every 12 weeks) to assess whether your current maintenance dose remains appropriate or requires adjustment.

Weight loss typically continues for 60-72 weeks on maintenance mounjaro doses before plateauing, at which point the focus shifts to weight maintenance rather than continued reduction [2]. If you regain more than 5% of your lost weight whilst on maintenance therapy, your prescriber may investigate contributing factors such as dietary changes, reduced physical activity, or medication adherence issues before considering dose adjustment. Mounjaro is licensed for long-term use, and many patients continue treatment indefinitely to maintain their weight loss, subject to ongoing prescriber approval.

Getting Started with Mounjaro at Cured Pharmacy

Beginning treatment with the correct mounjaro doses starts with a comprehensive clinical assessment by our UK-registered prescribers. The online consultation at Cured Pharmacy takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications to tirzepatide therapy. Unlike some providers, we display transparent upfront pricing — Mounjaro starts from £135.00 — so you'll know the cost before completing your assessment.

If approved, your prescription is dispensed from our GPhC-registered pharmacy (registration number 9012511) under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073). We supply only genuine UK-licensed Mounjaro KwikPens with full patient information leaflets and detailed injection instructions. Your first supply will be the 2.5mg starter dose, with subsequent prescriptions issued at four-week intervals as you progress through the escalation schedule, subject to ongoing prescriber approval at each stage.

Our clinical team provides ongoing support throughout your treatment journey, from initial 2.5mg doses through to maintenance therapy. You'll have access to prescriber follow-up consultations to discuss dose escalation, manage any side effects, and optimise your weight loss outcomes. All deliveries arrive in 100% discreet packaging, with no external markings indicating pharmacy or medication contents, and we guarantee the lowest prices in the UK for genuine licensed treatments.

What to Expect in Your First 12 Weeks

The initial 12 weeks of Mounjaro treatment cover three dose levels: 2.5mg for four weeks, 5mg for four weeks, and 7.5mg for four weeks. Most patients notice appetite suppression beginning at the 5mg dose, with measurable weight loss typically starting during the 5mg or 7.5mg phase [1]. It's normal to experience minimal weight change during the first 2.5mg month — this is an initiation dose, not a therapeutic dose, and patience during this phase leads to better long-term outcomes.

Schedule your weekly injections on the same day each week (many patients choose Sunday evenings or Monday mornings for consistency). You can change your injection day if needed, provided there are at least three days between doses — simply resume your new preferred day and maintain that schedule going forward. If you miss a dose by less than four days, take it as soon as you remember; if more than four days have passed, skip that dose and resume your regular schedule with the next injection [3].

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. NHS. (2024). Tirzepatide (Mounjaro). NHS UK. https://www.nhs.uk/medicines/tirzepatide/
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.